‘You give me fever!’: are health services ready for immune cell engager therapy in advanced solid malignancies?Claire Pettinger, Claire Livings, Rafael Grochot, Andrew Furness, Juanita Lopez
23 December 2022
Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 studyHaiping Jiang, Xiongfei Yu, Ning Li, Mei Kong, Zhimin Ma, Donghui Zhou, Weibin Wang, Haohao Wang, Haiyong Wang, Kuifeng He, Zhongqi Li, Yimin Lu, Jing Zhang, Kui Zhao, Yafei ZhangSee the full list of authors
16 March 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A Cuaboy, Amy L Garrett, Karen McKinnon, Kristen Cowens, Dante Bortone, Benjamin C Calhoun, Alec D WilkinsonSee the full list of authors
4 February 2022
GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumorsDavid G DeNardo, Anna Galkin, Jakob Dupont, Lei Zhou, Johanna Bendell
27 August 2021
Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trialDmitriy Zamarin, Sven Walderich, Aliya Holland, Qin Zhou, Alexia E Iasonos, Jean M Torrisi, Taha Merghoub, Lewis F Chesebrough, Autumn S Mcdonnell, Jacqueline M Gallagher, Yanyun Li, Travis J Hollmann, Rachel N Grisham, Courtney L Erskine, Mathew S BlockSee the full list of authors
4 June 2020
Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexesGuifang Guo, Yixing Wang, Yixin Zhou, Qi Quan, Yijun Zhang, Haohua Wang, Bei Zhang, Liangping Xia
12 July 2019
The motility regulator flhDC drives intracellular accumulation and tumor colonization of SalmonellaVishnu Raman, Nele Van Dessel, Owen M. O’Connor, Neil S. Forbes
12 February 2019
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsJacek Mackiewicz, Tomasz Burzykowski, Dariusz Iżycki, Andrzej Mackiewicz
29 November 2018
Quick efficacy seeking trial (QuEST1): a novel combination immunotherapy study designed for rapid clinical signal assessment metastatic castration-resistant prostate cancerJason M. Redman, Seth M. Steinberg, James L. Gulley
18 September 2018
Design considerations for early-phase clinical trials of immune-oncology agentsNolan A. Wages, Cody Chiuzan, Katherine S. Panageas
22 August 2018